1. Clinical and molecular characterization of Rubinstein‐Taybi syndrome patients carrying distinct novel mutations of the EP300 gene. (17th February 2014) Authors: Negri, G.; Milani, D.; Colapietro, P.; Forzano, F.; Della Monica, M.; Rusconi, D.; Consonni, L.; Caffi, L. G.; Finelli, P.; Scarano, G.; Magnani, C.; Selicorni, A.; Spena, S.; Larizza, L.; Gervasini, C. Journal: Clinical genetics Issue: Volume 87:Number 2(2015:Feb.) Page Start: 148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Histologic features of long‐lasting chilblain‐like lesions in a paediatric COVID‐19 patient. (8th June 2020) Authors: Locatelli, A.G.; Robustelli Test, E.; Vezzoli, P.; Carugno, A.; Moggio, E.; Consonni, L.; Gianatti, A; Sena, P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 8(2020) Page Start: e365 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗